Literature DB >> 16541466

Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice.

Christopher M Reilly1, Selen Olgun, David Goodwin, Robert M Gogal, Arben Santo, Jason W Romesburg, S Ansar Ahmed, Gary S Gilkeson.   

Abstract

To investigate the role of interferon regulatory factor-1 (IRF-1) in the development of lupus nephritis, IRF-1(-/-) genotype mice were bred onto the MRL/lpJfas(lpr) (MRL/lpr) background. We examined kidney mesangial cell function and disease progression. Endpoints evaluated included inflammatory mediators, autoantibody production, immune complex deposition, renal pathology, T cell subset analysis, and duration of survival. Mesangial cells cultured from IRF-1(-/-) mice produced significantly lower levels of nitric oxide and IL-12 but not TNF-alpha when stimulated with LPS + IFN-gamma. IRF-1(-/-) mice showed less aggravated dermatitis compared to the wild-type mice. Anti-double-stranded DNA production and proteinuria were significantly decreased in IRF-1(-/-) mice compared to IRF-1(+/+) mice. IgG and C3 deposition as well as glomerulonephritis were decreased in IRF-1(-/-) mice at 26 wk of age compared to the IRF-1(+/+) mice. Splenic CD4- CD8- CD44+ T cells were decreased while CD4+ CD25+ T cells were increased in the IRF-1(-/-) mice when compared to IRF-1(+/+) mice. Survival rates (ED50) were 22 wk for IRF-1(+/+) mice and 45 wk for IRF-1(-/-) mice. These findings suggest an important role of IRF-1 in mediating renal disease in MRL/lpr mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541466     DOI: 10.1002/eji.200535245

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Suppression of systemic autoimmunity by the innate immune adaptor STING.

Authors:  Shruti Sharma; Allison M Campbell; Jennie Chan; Stefan A Schattgen; Gregory M Orlowski; Ribhu Nayar; Annie H Huyler; Kerstin Nündel; Chandra Mohan; Leslie J Berg; Mark J Shlomchik; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  IRF4 deficiency abrogates lupus nephritis despite enhancing systemic cytokine production.

Authors:  Maciej Lech; Marc Weidenbusch; Onkar P Kulkarni; Mi Ryu; Murthy Narayana Darisipudi; Heni Eka Susanti; Hans-Willi Mittruecker; Tak W Mak; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2011-07-08       Impact factor: 10.121

3.  Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation.

Authors:  Lisha Liu; Wen Qiu; Hui Wang; Yan Li; Jianbo Zhou; Mei Xia; Kai Shan; Rongrong Pang; Ying Zhou; Dan Zhao; Yingwei Wang
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

Review 4.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

5.  Renal-infiltrating CD11c+ cells are pathogenic in murine lupus nephritis through promoting CD4+ T cell responses.

Authors:  X Liao; J Ren; A Reihl; T Pirapakaran; B Sreekumar; T E Cecere; C M Reilly; X M Luo
Journal:  Clin Exp Immunol       Date:  2017-08-18       Impact factor: 4.330

6.  Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.

Authors:  Jianhua Liu; Celine C Berthier; J Michelle Kahlenberg
Journal:  Arthritis Rheumatol       Date:  2017-08-08       Impact factor: 10.995

Review 7.  The biology of reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

8.  IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.

Authors:  Donna L Thibault; Alvina D Chu; Kareem L Graham; Imelda Balboni; Lowen Y Lee; Cassidy Kohlmoos; Angela Landrigan; John P Higgins; Robert Tibshirani; Paul J Utz
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

9.  Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.

Authors:  Julie Swenson; Selen Olgun; Ali Radjavi; Taranjit Kaur; Christopher M Reilly
Journal:  Eur J Pharmacol       Date:  2007-04-06       Impact factor: 4.432

10.  Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes.

Authors:  Z Zhang; L Song; K Maurer; M A Petri; K E Sullivan
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.